rs3803304 — AKT1

AKT1 rs3803304 — The Insulin Signaling Dimmer in the Longevity Pathway

AKT1 (also called protein kinase B, or PKB) is a master regulator sitting at the center of the insulin and IGF-1 signaling cascade — the most evolutionarily conserved longevity pathway known, from roundworms to humans. When insulin or IGF-1 binds its receptor, PI3K activates and recruits AKT1 to the cell membrane, where it is phosphorylated and switches on. From there, activated AKT1 reaches into nearly every aspect of cell survival, growth, and metabolism: it phosphorylates and inactivates FOXO3 (suppressing the stress-resistance transcription factor), activates mTOR (accelerating protein synthesis and suppressing autophagy), and regulates glucose uptake, apoptosis, and inflammatory signaling. The conserved nature of this pathway is remarkable¹¹ The conserved nature of this pathway is remarkable
Kenyon CJ. The genetics of ageing. Nature, 2010 — reducing insulin/IGF-1 signaling extends lifespan across every organism where this has been tested, from yeast to worms to flies to mice.

rs3803304 sits in intron 9 of AKT1, approximately 70 base pairs upstream of a conserved exon-intron boundary, in a region of high predicted regulatory potential that also contains a CpG island. Although intronic, it is not merely a passive passenger variant: cells bearing the minor G allele exhibit measurably elevated levels of phosphorylated AKT protein in both resting and stimulated conditions, suggesting the variant modulates AKT activation capacity rather than AKT expression alone. The proposed mechanism involves disruption of an RNA regulatory element at the nearby splice boundary, potentially affecting alternative splicing or transcript stability of specific AKT1 isoforms.

The Mechanism

AKT1's role in longevity operates through a central tension in cell biology: growth versus maintenance. Chronically elevated AKT activity drives mTORC1 phosphorylation of S6K1 and 4E-BP1 to push protein synthesis, cell growth, and proliferation — all beneficial in youth, but increasingly detrimental with age as they suppress autophagy (the cellular cleanup system), promote inflammatory signaling, and accelerate cellular senescence. Conversely, reducing AKT/mTOR activity below the threshold needed for unrestricted growth shifts cells toward the housekeeping functions that protect against aging²² reducing AKT/mTOR activity below the threshold needed for unrestricted growth shifts cells toward the housekeeping functions that protect against aging
Kenyon C. The genetics of ageing. Nature, 2010.

The G allele at rs3803304 appears to modestly increase AKT phosphorylation capacity, nudging the signaling axis toward higher chronic AKT activity. For AKT1's downstream targets, this translates to: increased phospho-FOXO3 (keeping the longevity transcription factor cytoplasmic and inactive), higher mTORC1 throughput (suppressing autophagy), and elevated inflammatory NF-kB signaling. Over decades, these small shifts compound into meaningful differences in cancer risk, cardiovascular aging, and overall lifespan.

The Evidence

The key longevity findings come from a systematic screen of 291 common variants across 30 insulin/IGF1 pathway genes. Pawlikowska et al. (2009)³³ Pawlikowska et al. (2009)
Association of common genetic variation in the insulin/IGF1 signaling pathway with human longevity. Aging Cell, 2009 genotyped three independent Caucasian cohorts: the Study of Osteoporotic Fractures (293 cases ≥92 years / 603 controls ≤79 years), the Cardiovascular Health Study, and Ashkenazi Jewish Centenarians. rs3803304 emerged as the top AKT1 signal, with homozygous GG individuals markedly underrepresented among long-lived cases (recessive model OR=0.41–0.50 across cohorts, unadjusted p=0.0004; per-allele OR=0.78, permutation-adjusted p=0.043). The effect followed a recessive pattern — single G-allele carriers showed no significant longevity disadvantage (p=0.12), but GG homozygotes were consistently depleted among centenarians across three independent populations.

The biological interpretation was strengthened by a subsequent functional study. Crezee et al. (2020)⁴⁴ Crezee et al. (2020)
Akt1 genetic variants confer increased susceptibility to thyroid cancer. Endocrine Connections, 2020 confirmed that carriers of the minor allele at rs3803304 — reported in coding-strand notation in that paper but corresponding to the G allele on the plus strand — exhibit elevated levels of phosphorylated AKT protein in both unstimulated and stimulated conditions. The same allele conferred OR=1.587 for non-medullary thyroid cancer in two independent European cohorts (Dutch: 154 cases / 188 controls; Romanian: 159 cases / 260 controls). Elevated AKT phosphorylation capacity provides a coherent biological link between this intronic variant and both cancer risk and reduced longevity probability: more active AKT means more suppressed FOXO3, more mTORC1 activity, and more proliferative cellular drive.

[A sex-stratified age-at-death analysis | TenNapel MJ et al. SIRT6 Minor Allele Genotype Is Associated with

5-Year Decrease in Lifespan in an Aged Cohort. PLOS One, 2014](https://pubmed.ncbi.nlm.nih.gov/25541994/⁵⁵ https://pubmed.ncbi.nlm.nih.gov/25541994/) found a significant gender interaction (p=0.04): CC women lived on average 2.2 years longer than GG women and 1.8 years longer than CG women, while males showed a modest opposite pattern. The sex-specificity aligns with the fact that the initial longevity discovery cohort (SOF) was exclusively female, and estrogen signaling is known to modulate AKT1 activity and downstream FOXO biology differently by sex.

The picture is incomplete: an independent replication by Nygaard et al. (2013)⁶⁶ Nygaard et al. (2013)
AKT1 fails to replicate as a longevity-associated gene in Danish and German nonagenarians and centenarians. Eur J Hum Genet, 2013 found no significant associations in 2,996 long-lived individuals and 1,840 controls, and a Han Chinese study Li et al. (2016)⁷⁷ Li et al. (2016)
Association study of polymorphisms in FOXO3, AKT1 and IGF-2R genes with human longevity in a Han Chinese population. Oncotarget, 2016 found no association either. The evidence remains moderate: consistent functional biology, initial multi-cohort discovery, plausible mechanism, but inconsistent replication across populations and likely population- and sex-specific effects.

Practical Actions

For GG homozygotes, the actionable implication centers on managing the consequences of elevated chronic AKT1 signaling. Since AKT activates mTORC1 and suppresses FOXO3 and autophagy, the most evidence-based counterstrategies are interventions that independently suppress mTOR and restore FOXO3 activity: periodic fasting or caloric restriction (which reduces insulin/IGF-1 levels and thus upstream AKT activation), protein cycling rather than continuous high-protein intake (BCAA/leucine drive mTOR independently of AKT), and resistance training (which paradoxically improves insulin sensitivity and normalizes the AKT signaling response over time).

GG individuals may also benefit from more proactive cancer surveillance given the thyroid cancer risk association, and from monitoring fasting insulin and IGF-1 levels as biomarkers of AKT pathway activity. Fasting insulin above 5–7 mIU/L at rest signals chronically elevated upstream signaling that would further amplify the variant's effect.

Interactions

rs3803304 operates squarely within the same longevity signaling network as FOXO3A rs2802292 and MTOR rs2295080. AKT1 phosphorylates and inactivates FOXO3 — so GG carriers at rs3803304 (elevated AKT activity) would be expected to show blunted FOXO3 signaling, potentially negating the protective benefit of the FOXO3 G-allele. Conversely, mTOR rs2295080 G-allele carriers already have lower mTOR expression; if AKT signaling is also elevated via rs3803304 GG, the net mTOR effect is unclear since AKT feeds into mTOR through TSC2. These combined PI3K-AKT-mTOR pathway interactions are biologically compelling but have not been formally tested in combined genotype studies. The Pawlikowska paper screened the full insulin/IGF1 axis and identified AKT1 and FOXO3A as the top signals, suggesting they tag partially independent longevity mechanisms within the same pathway.